Because unbiased pathway analysis returned three proven targets of RA, targeting other significant upstream regulators, namely TNFSF12 (TWEAK) and TLR7 may also exhibit therapeutic efficacy. Here, TNFSF12 is linked to rheumatoid arthritis.